TMDX logo

TMDX TransMedics Group, Inc.

NASDAQ Global Market · Medical - Devices · Healthcare

$85.25
-8.77 (-9.33%)

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system lev…

Market Cap: $2.96Bwww.transmedics.com

Price

$83.89-16.12%
$62.04$74.70$87.35$100.01
May 1Aug 7

Social Signal Score

58
5d
—
30d
58
19 mentions
+0.0%
60d
57
20 mentions
+0.0%
90d
57
23 mentions
+0.0%
news: 23

Analyst Ratings

13 analysts
Buyconsensus
Strong Buy 0Buy 9Hold 4Sell 0Strong Sell 0
Avg price target$100.43+17.8%
Low $65Median $106High $122
Current Consensus

Revenue

$203.00M+10837.77%
$1.86M$68.91M$135.96M$203.00M
Apr 2017Sep 2026

Analyst Estimates

FY2025
$2.60
$2.37–$2.81
7 analysts
FY2026
$1.63-37% YoY
$1.44–$1.76
7 analysts
FY2027
$2.46+51% YoY
$2.10–$3.05
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Waleed H. Hassanein
Sector
Healthcare
Industry
Medical - Devices
Employees
898
Beta
2.10
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
2.74
www.transmedics.com